Vorinostat (suberoylanilide hydroxamic acid, SAHA) is clinically active in advanced cutaneous T-cell lymphoma (CTCL): Results of a phase IIb trial.
暂无分享,去创建一个
T. Kuzel | Y. Kim | E. Olsen | M. Duvic | Youn H. Kim | F. Foss | S. Parker | S. Frankel | J. Lis | T. Pacheco | J. Wang